BackPT Millennium Pharmacon International Tbk Overview

PT Millennium Pharmacon International Tbk Long Term Debt

Latest long-term debt for SDPC.JK: $48B.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$47.93B
↓ 9.99% YoYΔ $-5.32B vs prior year quarter

Peer trimmed avg / median

Loading

PT Millennium Pharmacon International Tbk Long Term Debt History

Loading

PT Millennium Pharmacon International Tbk vs. peers: Long Term Debt Comparison

Loading

PT Millennium Pharmacon International Tbk Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

PT Millennium Pharmacon International Tbk (SDPC.JK) FAQ

The latest long-term debt for SDPC.JK is $48B as of September 2026. That compares with $53B in the prior-year period — down 10.0% year over year. Investors often review this figure alongside PT Millennium Pharmacon International Tbk's historical trend and sector peers before judging valuation or financial health.

Over the past year, SDPC.JK's long-term debt moved from $53B to $48B — a 10.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in PT Millennium Pharmacon International Tbk's operating scale or balance-sheet position.

A long-term debt figure of $48B for SDPC.JK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SDPC.JK's long-term debt ($48B), review year-over-year change from $53B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers